Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Treon

Showing results (61-70 of 323) with videos related to

Pageof 33
Sort By:
American Journal of Hematology|March 20, 2016
Atrial fibrillation associated with ibrutinib in Waldenström macroglobulinemiaJoshua N Gustine, Kirsten Meid, Toni E Dubeau, et al.
British Journal of Haematology|February 19, 2025
Zanubrutinib for the treatment of Bing-Neel syndromeShayna Sarosiek, Andres Ramirez-Gamero, Catherine A Flynn, et al.
Seminars in Oncology|April 30, 2003
Novel biologically based therapies for Waldenstrom's macroglobulinemiaConstantine S Mitsiades, Nicholas Mitsiades, Paul G Richardson, et al.
British Journal of Haematology|November 3, 2015
Rituximab intolerance in patients with Waldenström macroglobulinaemiaJorge J Castillo, Sandra Kanan, Kirsten Meid, et al.
Blood|June 21, 2014
Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results databaseJorge J Castillo, Adam J Olszewski, Angel M Cronin, et al.
British Journal of Haematology|August 6, 2021
Plasmablastic lymphoma transformation in a patient with Waldenström macroglobulinemia treated with ibrutinibJorge J Castillo, John LaMacchia, Catherine A Flynn, et al.
American Journal of Hematology|July 15, 2016
Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemiaJorge J Castillo, Joshua Gustine, Kirsten Meid, et al.
Hematology/Oncology Clinics of North America|September 8, 2018
Genomic Landscape of Waldenström MacroglobulinemiaSteven P Treon, Lian Xu, Xia Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Genomics, Signaling, and Treatment of Waldenström MacroglobulinemiaZachary R Hunter, Guang Yang, Lian Xu, et al.
Expert Review of Hematology|July 26, 2019
CXCR4 mutations affect presentation and outcomes in patients with Waldenström macroglobulinemia: A systematic reviewJorge J Castillo, David F Moreno, Maria I Arbelaez, et al.
Pageof 33

Showing results (61-70 of 323) with videos related to

Sort By:
Pageof 33
American Journal of Hematology|March 20, 2016
Atrial fibrillation associated with ibrutinib in Waldenström macroglobulinemiaJoshua N Gustine, Kirsten Meid, Toni E Dubeau, et al.
British Journal of Haematology|February 19, 2025
Zanubrutinib for the treatment of Bing-Neel syndromeShayna Sarosiek, Andres Ramirez-Gamero, Catherine A Flynn, et al.
Seminars in Oncology|April 30, 2003
Novel biologically based therapies for Waldenstrom's macroglobulinemiaConstantine S Mitsiades, Nicholas Mitsiades, Paul G Richardson, et al.
British Journal of Haematology|November 3, 2015
Rituximab intolerance in patients with Waldenström macroglobulinaemiaJorge J Castillo, Sandra Kanan, Kirsten Meid, et al.
Blood|June 21, 2014
Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results databaseJorge J Castillo, Adam J Olszewski, Angel M Cronin, et al.
British Journal of Haematology|August 6, 2021
Plasmablastic lymphoma transformation in a patient with Waldenström macroglobulinemia treated with ibrutinibJorge J Castillo, John LaMacchia, Catherine A Flynn, et al.
American Journal of Hematology|July 15, 2016
Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemiaJorge J Castillo, Joshua Gustine, Kirsten Meid, et al.
Hematology/Oncology Clinics of North America|September 8, 2018
Genomic Landscape of Waldenström MacroglobulinemiaSteven P Treon, Lian Xu, Xia Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Genomics, Signaling, and Treatment of Waldenström MacroglobulinemiaZachary R Hunter, Guang Yang, Lian Xu, et al.
Expert Review of Hematology|July 26, 2019
CXCR4 mutations affect presentation and outcomes in patients with Waldenström macroglobulinemia: A systematic reviewJorge J Castillo, David F Moreno, Maria I Arbelaez, et al.
Pageof 33